Ikarian Capital, LLC
Ikarian Capital, LLC latest Q4_2020 13F filings reported $547,468,000 in market value on this 2021-02-12 report date . The portfolio quarterly return is 52.22%. This fund has 134 securities concentrations of 100% weights.
Ikarian Capital, LLC largest holding is TRACON Pharmaceuticals Inc. with weight of 5.81% and $31,787,000 in market value. The portfolio return is computed based on the amount invested in the new quarter. The following shows the portfolio details.
Portfolio Performance History
|FILE DATE||REPORT PERIOD||QTR YEAR||FILE TYPE||NOS. OF STOCKS||REPORTED VALUE||RETURN|